| 2026-10-27 | Resumed | Piper Sandler | Neutral |
| 2026-10-16 | Hochstufung | Roth Capital | Neutral → Buy |
| 2026-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2026-09-10 | Resumed | Stifel | Hold |
| 2026-09-03 | Eingeleitet | Seaport Research Partners | Buy |
| 2026-07-08 | Hochstufung | Evercore ISI | Underperform → Outperform |
| 2026-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-05-21 | Hochstufung | Goldman | Sell → Neutral |
| 2026-03-24 | Eingeleitet | Truist | Hold |
| 2026-03-20 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-03-12 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-03-12 | Hochstufung | Wells Fargo | Underweight → Overweight |
| 2026-01-21 | Resumed | Barclays | Equal Weight |
| 2025-12-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-17 | Eingeleitet | Wells Fargo | Underweight |
| 2025-10-03 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-10-03 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-08-20 | Eingeleitet | Melius | Hold |
| 2025-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-04-08 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-01-31 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-08 | Resumed | JP Morgan | Neutral |
| 2024-10-17 | Resumed | BofA Securities | Neutral |
| 2024-10-02 | Resumed | Goldman | Neutral |
| 2024-07-18 | Resumed | Wolfe Research | Outperform |
| 2024-05-16 | Herabstufung | Truist | Buy → Hold |
| 2024-04-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-10 | Eingeleitet | Barclays | Equal Weight |
| 2024-04-08 | Eingeleitet | HSBC Securities | Hold |
| 2024-01-03 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-12-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-11-10 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-30 | Eingeleitet | Stephens | Overweight |
| 2023-04-19 | Eingeleitet | UBS | Neutral |
| 2023-03-28 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-02-22 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2023-02-14 | Hochstufung | Goldman | Neutral → Buy |
| 2023-01-10 | Resumed | Mizuho | Buy |
| 2023-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-14 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-11-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-19 | Herabstufung | Tudor, Pickering, Holt & Co. | Buy → Hold |
| 2022-07-20 | Resumed | MKM Partners | Neutral |
| 2022-07-11 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-04-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-06 | Eingeleitet | Stifel | Buy |
| 2022-03-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-05 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-12-09 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-10-18 | Hochstufung | Truist | Hold → Buy |
| 2021-09-29 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-08-31 | Eingeleitet | Citigroup | Buy |
| 2021-06-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-06-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-27 | Hochstufung | Goldman | Neutral → Buy |
| 2021-05-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-04-14 | Hochstufung | MKM Partners | Neutral → Buy |
| 2021-04-12 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-03-23 | Resumed | Goldman | Neutral |
| 2021-03-11 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2021-02-08 | Bestätigt | BofA Securities | Buy |
| 2021-01-19 | Eingeleitet | Societe Generale | Hold |
| 2021-01-12 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-12-17 | Resumed | Evercore ISI | In-line |
| 2020-12-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-12-07 | Herabstufung | MKM Partners | Buy → Neutral |
| 2020-12-01 | Herabstufung | UBS | Neutral → Sell |
| 2020-11-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2020-11-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-21 | Herabstufung | Truist | Buy → Hold |
| 2020-09-24 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-09-08 | Hochstufung | MKM Partners | Neutral → Buy |
| 2020-08-21 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-08-18 | Hochstufung | Tudor Pickering | Sell → Hold |
| 2020-08-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-08-05 | Resumed | Credit Suisse | Underperform |
| 2020-06-19 | Hochstufung | SunTrust | Hold → Buy |
| 2020-06-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-06-04 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-06-01 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-05-18 | Hochstufung | Standpoint Research | Hold → Buy |
| 2020-05-07 | Hochstufung | SunTrust | Sell → Hold |
| 2020-05-04 | Herabstufung | Tudor Pickering | Hold → Sell |
OXY
